Spontaneous Remission of a Bony Metastasis in Prostatic Adenocarcinoma

Schurmans, Johan; Blijenberg, B. G.; Mickisch, G.; Schröder, Fritz H.

doi:10.1016/s0022-5347(01)66486-3

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2001

2010

Publication Types

Select...

Article5

Book1

Relationship

Self Cite0

Independent6

Authors

Journals

Cited by 9 publications

(1 citation statement)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This phenomenon is thought to occur as a result of immune mediated mechanisms. [1][2][3][4][5][6][7][8] In RCC, spontaneous regression has been reported most frequently in the setting of metastatic disease, usually associated with treatment of the primary lesion. [9][10][11][12][13] Various immunological mechanisms have been proposed to account for this association.…”

Section: Introductionmentioning

confidence: 99%

Immunological therapy in urological malignancy: Novel combination strategies

et al. 2010

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Immunological therapy in urological malignancy: Novel combination strategies

et al. 2010

View full text Add to dashboard Cite

show abstract

Fever, Pyrogens and Cancer

Kleef¹,

Hager

Medical Intelligence Unit

View full text Add to dashboard Cite

Molecular-based therapies for renal cell carcinoma

Zisman

Belldegrun

2001

Curr Urol Rep

View full text Add to dashboard Cite

The incidence of renal cell carcinoma (RCC) is rising steadily, but the ability to cure patients with metastatic RCC unfortunately remains limited. Emerging interest in gene therapy performance and safety is expressed by patients, medical institutes, and other agencies. It has become evident that better understanding of the genetic impairments and immune pathophysiology in RCC is essential for future improvement in patient care. Clinical trials now underway that are focusing on genetic and immune impairments will hopefully lead to future breakthroughs in RCC therapy. This paper reviews available gene therapies and other related therapeutic approaches for RCC and lists some of the current clinical trials focused on molecular-based therapies.

show abstract

Spontaneous Remission of a Bony Metastasis in Prostatic Adenocarcinoma

Cited by 9 publications

References 2 publications

Immunological therapy in urological malignancy: Novel combination strategies

Immunological therapy in urological malignancy: Novel combination strategies

Fever, Pyrogens and Cancer

Molecular-based therapies for renal cell carcinoma

Contact Info

Product

Resources

About